Microglia are the resident macrophages of the central nervous system (CNS), implicated in developmental processes, homeostasis, and responses to injury. Derived from the yolk sac during development, microglia self-renew, selfregulate their numbers during homeostatic conditions, and show a robust proliferative capacity even in adulthood. Together with monocyte-derived macrophages (MDM), microglia coordinate the regeneration of CNS myelin around axons, termed remyelination. Gene expression analyses and experimental modelling have identified pro-remyelination roles for microglia/ MDM in clearance of myelin debris, secretion of growth factors, and remodelling of the extracellular matrix. Further investigations into the molecular mechanisms controlling these regenerative functions will reveal novel therapeutic strategies to enhance remyelination, via harnessing the beneficial effects of the innate immune response to injury. Herein is our revised version of the review article CONEUR_2017_101 'Microglia: origins, homeostasis, and roles in myelin repair'. We appreciate the reviewer's comment that the review is well written, concise, and timely, and have addressed all the suggestions which have been highlighted in yellow in the text, and described below:
The discussion of the differing transcriptional profiles of resident microglia and MDMs during demyelination is interesting but would be complemented by greater focus on the few studies that have shown functional differences between the two populations. The description of the recent TNFR2 ablation study by Gao In addition to the description of distinct microglia and MDM functions in EAE from Yamasaki and Lewis papers, we have now added the following to the main text: 'Other studies have demonstrated the requirement for MDM in initiating EAE disease and progression 51 via CCR2 signalling 52, 53 ; accordingly, Yamasaki et al. showed that MDMs in close association with axoglial units have myelin inclusions 49 , suggesting that these cells may directly induce demyelination', referencing the above studies and some additional ones we found were relevant. 
Introduction
Microglia are the resident tissue macrophages in the central nervous system (CNS), comprising 5-12 % of total neural cells in mouse brain and 0.5-16% in human brain 1, 2 . As members of the innate immune system, a major function of microglia is to survey the microenvironment for signs of injury, such as damage-associated molecular patterns (DAMPs) released from dying or stressed cells. As such, microglia are early responders to CNS damage or abnormality and are thus placed to quickly coordinate subsequent responses. These can be damaging, for instance in contributing to neurodegeneration 3 , dysregulated synaptic pruning 4 , and associated with dementia 5 , reviewed in detail elsewhere 6 . However, although less studied, microglial post-injury responses can also be regenerative; indeed, studies over the past 16 years have revealed the supportive role of macrophages (i.e. microglia and monocyte-derived macrophages (MDMs)) in the regeneration of myelin, termed remyelination [7] [8] [9] [10] [11] [12] [13] [14] [15] .
Remyelination reinstates and preserves axonal function and health [16] [17] [18] [19] [20] . This involves recruitment and proliferation of oligodendrocyte progenitor cells (OPCs), their differentiation into mature oligodendrocytes, and ensheathment of axons with new myelin.
The failure of remyelination in various neurological contexts, such as with ageing and in progressive multiple sclerosis (MS), is considered to contribute to the axonal loss which correlates to decline in motor, sensory, and cognitive functions. Failed remyelination with ageing has been associated with dysregulated macrophage responses in experimental models 10, 11, 21 , highlighting a key pro-regenerative therapeutic target. Although clinical trials aimed at enhancing remyelination by directly stimulating oligodendrocyte lineage cells are currently ongoing for the first time, whether these drugs will be successful, and whether they will work efficiently in all patients, remains to be seen. Given the plethora of evidence implicating macrophages in remyelination in both rodent and human pathological studies, further investigations into microglia biology will reveal novel therapeutic strategies based on manipulating the innate immune response. Here, we summarize current knowledge on microglia development, homeostasis, and gene expression/ functions during remyelination.
Origins, maintenance, & repopulation of microglia during homeostasis
Microglia regulate developmental processes, including but not limited to oligodendrocyte differentiation 22 , neural precursor migration 23 , and synaptic pruning 24 . Accordingly, microglia arise early on in development, populating the murine neuroepithelium by embryonic day 9.5 (E9.5) 25 , and subsequently being closed off from the periphery by the formation of the blood brain barrier by E13.5. Between E10.5 and birth, microglia rapidly proliferate to colonise the CNS, maturing into ramified microglia 26 After birth, microglial numbers initially increase in the first two weeks of life, followed by a decrease to a steady homeostatic level via apoptosis and reduced proliferation 35, 36 . Under homeostatic conditions, yolk-sac derived microglia were historically considered to be longlived cells with low turnover. However, recent evidence has shown that the microglia population in the mouse brain is dynamically regulated at the individual cell level via coupling of apoptosis and proliferation, with a minimum of 1.38% of microglia estimated to be proliferating (as shown by BrdU incorporation) at any given time and 1.23% of microglia dying every 24 hours 37 . Altogether, it is therefore estimated that a whole microglial population in the murine CNS can turn over in 96 days. In human brain, slightly higher rates of proliferation were observed (Ki67 + Iba-1 + cells) 37 , but rates of death are unknown.
Dynamic regulation of the microglia population in the adult mouse brain has also been observed by repopulation from CNS-endogenous cells following global depletion of microglia [38] [39] [40] [41] . These studies involved adult mice, thereby revealing that repopulation of microglia occurs in a mode distinct from the original seeding in development. There are currently 2 proposed models of microglia repopulation. The first study, using a Cx3cr1-CreERT2;iDTR mouse model, ablated a minimum of 80% of microglia in the cortex, cerebellum, and spinal cord by 3 days post-diphtheria toxin 40 . A subsequent rapid repopulation was observed at 7 days post-diphtheria toxin, mediated by self-renewing proliferating microglia (expressing Nestin), with numbers returning back to control levels 1 week later 40 . The second model, where >90% of microglia were depleted using a CSF1R inhibitor, observed repopulation from a CX3CR1-negative CNS-resident cell 39 . BrdU labelling showed that 70% of labelled cells were positive for Nestin but negative for microglia markers such as Iba-1. When repopulation was complete, almost all BrdU labelled cells were positive for microglial markers, leading to the conclusion that the Nestin+ cells differentiated into microglia 39 . These repopulating cells heterogeneously expressed a range of markers for hematopoietic stem cells or neural stem cells including Nestin, CD34, and ckit, as well as lectin-IB4, CD45, and Ki67 39 . Further investigations showed that the repopulated microglia have similar inflammatory gene expression and functional responses to lipopolysaccharide compared to pre-depletion microglia 39 , however the identity and origin of these cells remains unclear and is hotly debated. Definitive lineage tracing and RNA-sequencing of Nestin+ cells should ultimately uncover their identity and role in the CNS. Differences in between these two studies may reflect different levels of depletion (>99% 39 compared to 80% 40 ) , and only the DTR-driven depletion leading to a robust pro-inflammatory response and astrogliosis 40 . Although there is uncertainty as to the role of Nestin in microglia repopulation, be it re-expression by residual microglia 40 or cells potentially capable of differentiating into microglia 39 , it is clear that cells expressing Nestin are nonetheless integral to the rapid repopulation of microglia following depletion.
Determining whether the dynamic regulation of microglial turnover/ repopulation is dysregulated in the context of failed remyelination may be critical in understanding how to therapeutically target microglia.
Transcriptional profiles of microglia and monocyte-derived macrophages during central nervous system remyelination
The importance of inflammation and microglia/ MDM in remyelination was initially suggested by transcriptomic studies of whole remyelinating lesions. For example, a microarray gene expression analysis of whole mouse brain tissue following cuprizone toxininduced demyelination revealed regulation of genes associated with inflammation and/or the recruitment/stimulation of macrophages. For instance, lysozyme M (LyzM) and leukocyte common antigen/CD45 (Ptprc), and genes associated with recruitment/ activation of macrophages (Ccl2 (MCP-1), Ccl9 (MIPγ), Ccr5, Mmp12), were upregulated at the time of concomitant demyelination and initiation of remyelination (6 weeks after initiation of cuprizone treatment) and subsequently downregulated during the later stages of remyelination (6 weeks recovery on normal diet) 42 . Downregulation of these genes during late remyelination coincided with the upregulation of myelin-associated genes (such as proteolipid protein 1 (Plp), myelin associated glycoprotein (Mag), myelin oligodendrocyte glycoprotein (Mog)), as well as synectin (Gipc1), BCL tumour suppressor 7C (Bcl7c), lysophosphatidic acid receptor 1 (Lpar1; important for Schwann cell myelination 43 ), kinesin family member 5A (Kif5a; required for transport of neurofilament), and NK6 transcription factor related (Gtx; expressed during myelination and remyelination 44 ). To further identify genes involved in remyelination, Arnett, et al. 45 analysed whole brains isolated from Tnfa -/-mice, which do not remyelinate efficiently after cuprizone-induced demyelination. In comparison to wildtype mice, microarray analysis identified differential expression of genes during remyelination (6 weeks recovery on normal diet after 6 weeks of cuprizone diet) 45 .
Importantly, these studies support that the immune response is a critical component of remyelination; however, these results do not reflect transcriptional profiles of individual cell populations. Indeed, Srinivasan, et al. 46 showed that the expression profiles of cells extracted from tissues affected by neurodegenerative disease are influenced by cell composition, and whole tissue RNA analysis may obscure significant gene changes in microglia and, thus, could be misleading. Similarly, some studies have combined microglia and MDM together for analysis, as a result of the challenges of distinguishing and isolating microglia from MDM 47 . To overcome this, Lewis, et al. 48 isolated microglia from MDM by fluorescence-activated cell sorting (FACS) using differential expression of the surface marker CD44, and investigated the transcriptomes of these cell populations in the pathogenesis of experimental autoimmune encephalomyelitis (EAE). Microglia and MDM were isolated from naive mouse brains when clinical symptoms were absent (at 7 days post immunisation; disease score of 0) and when partial hind-limb paralysis was observed (at 14 days post immunisation; disease score of 3), and transcriptomes were determined using RNA sequencing. Principal component analysis revealed that the two cell populations remained distinct at the transcriptome level during the course of EAE. The distinct microglia and MDM expression profiles during EAE were confirmed in a separate study 49 50 . Other studies demonstrated the requirement for MDM in initiating EAE disease and progression 51 via CCR2 signalling 52, 53 ; accordingly, Yamasaki et al.
showed that MDMs in close association with axoglial units have myelin inclusions 49 , suggesting that these cells may directly induce demyelination. These studies highlight the differential functions of microglia and macrophages during myelin injury, and point to the requirement to analyse these populations separately to accurately assess their roles during remyelination.
Using this approach, Olah et al. performed microarray analysis of microglia isolated from cuprizone-treated mice and identified 6200 genes expressed during homeostasis, demyelination and remyelination 13 . The major patterns observed were i) downregulation of metabolic processes and acute inflammatory responses during demyelination and remyelination; ii) upregulation of cell cycle during demyelination only; and iii) upregulation of immune response, phagocytosis and antigen processing/presentation during demyelination and remyelination 13 . However, the microglial transcriptome was largely similar between demyelination/ early remyelination (5 weeks cuprizone treatment) and late remyelination (5 weeks cuprizone treatment then 2 weeks recovery). At both these time points, microglia upregulated expression of toll-like receptor 4 (Tlr4), lysozyme 1 and 2 (Lyz1, Lyz2), tumour necrosis factor (Tnf), interleukin 1β (Il1b), interleukin receptor 4α (Il4ra), genes associated with MHC-II (Cd74, H2Aa), whilst common microglial markers such as Iba1 (Aif1), F4/80 (Emr1), and Pu.1 (Spi1) were stably expressed. The authors proposed numerous microglial effector functions during demyelination and remyelination, including phagocytosis of debris/ apoptotic cells, salvage of myelin constituents, recruitment of OPCs and trophic support, and tissue remodelling. Overall, this study highlighted that the overarching role of microglia is to maintain tissue homeostasis and to provide an environment supportive of regeneration, which was even evident during demyelination.
A significant function associated with microglia is the clearance of myelin debris, which is required for remyelination to occur. Impaired removal of myelin debris is one factor contributing to poor remyelination following cuprizone treatment of Trem2 -/-mice 54 . This is underpinned by impaired upregulation of genes associated with phagocytosis of myelin debris (Axl) and molecules central to lipid transport and metabolism (apolipoprotein-E (Apoe), apolipoprotein C1 (Apoc1), lipoprotein lipase (Lpl), cholesterol 25-hydroxylase (Ch25h)) during demyelination and remyelination. Furthermore, microglia provide trophic support to newly recruited OPCs, and a growth factor critical for OPC differentiation (insulinlike growth factor 1; Igf1) was found to be downregulated in Trem2 -/-mice after cuprizoneinduced demyelination. Together, these results suggest that a central role of microglia in responding to demyelination is to carry out myelin clearance and promote OPC maturation for remyelination to occur efficiently. These studies have elucidated microglia gene expression profiles during demyelination and remyelination, however subsequent unbiased investigations into expression profiles of microglia versus MDM during remyelination may reveal cell-specific functions during regeneration.
Functional contributions of microglia and monocyte-derived macrophages to central nervous system remyelination
Activated macrophages are a component of remyelinating lesions in both experimental models and human disease (e.g. multiple sclerosis, spinal cord injury, Alzheimer's disease) 55 .
For instance, the density of macrophages (HLA-DR+) at the border of MS lesions coincides with areas of robust remyelination 56 . In contrast to experimental models with concurrent demyelination and remyelination (such as EAE and the cuprizone model), focal toxininduced lesion models with temporally distinct damage and regeneration are the most appropriate to specifically associate cellular responses/ gene expression profiles/ molecules with the regenerative response to damage. Indeed, a recent study identified that remyelination is limited in EAE and occurs only at very late stages 20 . Conversely, focal models show robust remyelination (in young animals) following injection of demyelinating agents (such as lysolecithin, ethidium bromide, or lysophosphatidylserine (LPS)) into white matter tracts such as the spinal cord, corpus callosum, or caudal cerebellar peduncles. These models have been imperative in linking the beneficial effects of the immune response to the regulation of OPC responses during remyelination [7] [8] [9] [10] [11] 57 . More specifically, this allowed for the discovery that macrophages are required for efficient remyelination, given that blocking the macrophage response soon after demyelination, either via depletion using clodronateliposomes 7, 10 or by administration of minocycline 58 , inhibits remyelination. Furthermore, inducing macrophage activation is sufficient to enhance myelination or remyelination, for example via stimulation with the Toll-like receptor (TLR)-4 agonist LPS 59 , TLR-2 agonist zymosan 60 , or a combination of the anti-fungal agent amphotericin B with macrophage colony stimulating factor (M-CSF) 14 .
Our recent work has identified that efficient remyelination requires the dynamic regulation of functional macrophage phenotypes 10 . More specifically, soon after demyelination macrophages adopt expression of inducible nitric oxide synthase (iNOS), CD16/32, and tumor necrosis alpha (TNF-α), and support the proliferation of OPCs, yet these proinflammatory macrophages are not required for remyelination to proceed 10 . Importantly, the rate limiting step in remyelination efficiency is the transition to a pro-regenerative macrophage phenotype expressing arginase-1, mannose receptor (CD206), and insulin-like growth factor-1 (IGF-1) which drives oligodendrocyte differentiation to initiate remyelination 10 . Lineage tracing identified that both microglia and MDM contributed to both phenotypes 10 . Additionally, using Ccr2 knockout mice in which monocytes cannot extravasate from bone marrow and are thus excluded from lesions, we observed that microglia could undergo this transition in activation even in the absence of MDM 10 .
Although the molecular mechanisms underpinning this critical transition in macrophage activation are unknown, microglia and MDM gene expression/ activation can be manipulated by electrical nerve stimulation 61 , antipsychotic drug/ calcium suppression 62 , inhibition of Rho Kinase 63 , modulation of signalling through NFκB (reviewed by Lloyd and Miron 64 ), and histone deacetylase (HDAC) inhibition 65 .
The aforementioned phagocytosis of myelin debris by macrophages is required for remyelination to proceed, as this debris is otherwise inhibitory for the recruitment/ differentiation of oligodendrocyte lineage cells 9 and potentially for new myelin sheath extension 66 . Indeed, in MS lesions, the density of oligodendrocyte precursor cells (O4 + ) is proportional to the density of macrophages which have phagocytosed debris 67 instance by degrading chondroitin sulfate proteoglycans [73] [74] [75] . Microglia and MDMs may also coordinate a pro-remyelination environment via interaction with other cell types. For instance, a recent study identified that regulatory T cells drive remyelination 57 , and one may speculate that macrophages and regulatory T cells may cooperate to support regeneration.
Indeed, a recent study found that a secreted phenylalanine oxidase termed interleukin-4-induced-1 (IL4l1), which is highly enriched in microglia and upregulated during remyelination, regulates both macrophage activation during remyelination and reduces T cell expansion in EAE, leading to less dystrophic axons 76 . Using cultures of primary human neural cells, another study found that microglia release cytokines which modulate astrocytes, which in turn influence OPC responses 77 .
Importantly, the failure of remyelination seen with ageing is associated with a reduced recruitment of macrophages, reduced activation to a pro-regenerative macrophage phenotype 10, 78 , and impaired phagocytic potential 11, 21, 78 . Altogether, these findings point towards the importance of regulating macrophages following demyelination for efficient remyelination to take place, and the need for macrophage-specific targeting in developing effective therapeutic strategies for the enhancement of remyelination.
Conclusions
As sensors of damage in the central nervous system, microglia are early responders to injury, such as demyelination, and have roles in supporting the regenerative process of remyelination. Transcriptomics and functional assays have identified these to include the phagocytosis of myelin debris, remodelling of the extracellular matrix, and secretion of factors influencing oligodendrocyte lineage cell responses (such as differentiation into myelinating oligodendrocytes). Although microglia are likely supported by MDMs in many of these functions, whether there are distinct roles of the endogenous and exogenouslyderived macrophages during remyelination, as observed during myelin injury, is unknown. It also remains to be determined whether the dynamic turnover of microglia observed during homeostasis is altered during injury and remyelination. Nonetheless, the numerous studies implicating macrophages in supporting remyelination highlight that these cells are important therapeutic targets for promoting remyelination in various neurological disorders characterized by poor myelin integrity.
Figure legend
In development, erythromyeloid progenitors (EMPs) derived from the yolk sac colonize the embryonic brain (at embryonic day 9.5 in mice, and gestational week (gw) 4.5 and 12-13 in human). Mouse studies showed these cells will express Runx1, Pu.1, Irf8, Sall1, and Sall3. 
